PT1214302E - 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase - Google Patents

3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase

Info

Publication number
PT1214302E
PT1214302E PT00962346T PT00962346T PT1214302E PT 1214302 E PT1214302 E PT 1214302E PT 00962346 T PT00962346 T PT 00962346T PT 00962346 T PT00962346 T PT 00962346T PT 1214302 E PT1214302 E PT 1214302E
Authority
PT
Portugal
Prior art keywords
alcoxy
oes
oxadiazol
phenyl
substituted
Prior art date
Application number
PT00962346T
Other languages
English (en)
Inventor
Karl Schonafinger
Baringhaus Dr Karl-Heinz
Stefan Petry
Guenter Mueller
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT1214302E publication Critical patent/PT1214302E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
PT00962346T 1999-09-04 2000-08-22 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase PT1214302E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln

Publications (1)

Publication Number Publication Date
PT1214302E true PT1214302E (pt) 2004-03-31

Family

ID=7920884

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00962346T PT1214302E (pt) 1999-09-04 2000-08-22 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase

Country Status (30)

Country Link
US (1) US6596742B1 (pt)
EP (1) EP1214302B1 (pt)
JP (1) JP2003508522A (pt)
KR (1) KR100723817B1 (pt)
CN (1) CN1152024C (pt)
AR (1) AR032430A1 (pt)
AT (1) ATE253059T1 (pt)
AU (1) AU781330B2 (pt)
BR (1) BR0013765A (pt)
CA (1) CA2383731A1 (pt)
CZ (1) CZ2002772A3 (pt)
DE (2) DE19942354A1 (pt)
DK (1) DK1214302T3 (pt)
EE (1) EE04811B1 (pt)
ES (1) ES2204685T3 (pt)
HK (1) HK1048318B (pt)
HR (1) HRP20020187A2 (pt)
HU (1) HUP0202988A3 (pt)
IL (2) IL148275A0 (pt)
MX (1) MXPA02001834A (pt)
NO (1) NO323129B1 (pt)
NZ (1) NZ517551A (pt)
PL (1) PL197314B1 (pt)
PT (1) PT1214302E (pt)
RU (1) RU2265600C2 (pt)
SK (1) SK285924B6 (pt)
TR (1) TR200200553T2 (pt)
WO (1) WO2001017981A1 (pt)
YU (1) YU10402A (pt)
ZA (1) ZA200201594B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
JP2008515986A (ja) * 2004-10-13 2008-05-15 ワイス Ｎ−ベンゼンスルホニル置換アニリノ−ピリミジン類似物
EP2178821A2 (en) * 2007-07-12 2010-04-28 Deviris Inc. Hormone sensitive lipase modulators and methods of use
JP2011507952A (ja) * 2007-12-27 2011-03-10 バイアル−ポルテラ アンド シーエー，エス．エー． 医療用途用５−ｏ−置換３−ｎ−フェニル−１、３、４−オキサジアゾロン類
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
DE3267258D1 (en) 1981-06-15 1985-12-12 Shell Int Research 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
DE50004274D1 (de) 2003-12-04
CA2383731A1 (en) 2001-03-15
NO20021007D0 (no) 2002-02-28
MXPA02001834A (es) 2002-08-12
CN1152024C (zh) 2004-06-02
DE19942354A1 (de) 2001-03-08
AU781330B2 (en) 2005-05-19
DK1214302T3 (da) 2004-02-16
HRP20020187A2 (en) 2004-02-29
KR20020024336A (ko) 2002-03-29
HK1048318B (zh) 2004-12-10
TR200200553T2 (tr) 2002-06-21
JP2003508522A (ja) 2003-03-04
PL197314B1 (pl) 2008-03-31
EP1214302A1 (de) 2002-06-19
ATE253059T1 (de) 2003-11-15
WO2001017981A1 (de) 2001-03-15
YU10402A (sh) 2004-11-25
CN1371369A (zh) 2002-09-25
IL148275A0 (en) 2002-09-12
EE200200109A (et) 2003-06-16
NO20021007L (no) 2002-02-28
BR0013765A (pt) 2002-04-30
SK285924B6 (sk) 2007-11-02
ZA200201594B (en) 2003-04-30
HUP0202988A3 (en) 2004-12-28
RU2265600C2 (ru) 2005-12-10
ES2204685T3 (es) 2004-05-01
HK1048318A1 (en) 2003-03-28
PL353214A1 (en) 2003-11-03
NZ517551A (en) 2003-10-31
US6596742B1 (en) 2003-07-22
IL148275A (en) 2008-08-07
CZ2002772A3 (cs) 2002-05-15
AU7411200A (en) 2001-04-10
AR032430A1 (es) 2003-11-12
SK3012002A3 (en) 2002-06-04
EE04811B1 (et) 2007-04-16
HUP0202988A2 (hu) 2002-12-28
NO323129B1 (no) 2007-01-08
KR100723817B1 (ko) 2007-06-04
EP1214302B1 (de) 2003-10-29

Similar Documents

Publication Publication Date Title
PT1181017E (pt) Inibidores de metaloproteases
DK1139739T3 (da) Agrokemiske præparater
PT1194404E (pt) Inibidores de aspartil-protease
PT958287E (pt) Inibidores de sulfamida-metaloprotease
PT1218009E (pt) Grandulos de quetiapina
DE60021170D1 (de) Verstärker
ES1044448Y (es) Auto-aplicador de vendaje
DE60022929D1 (de) Konische Lagereinheit
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
PT1218096E (pt) Microcapsulas de libertacao variavel
PT1214302E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase
FR2774599B1 (fr) Cataplasme
PT1047665E (pt) Inibidores de metaloproteases de matriz
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
DK2277999T3 (da) Lipase variant
DE60024101D1 (de) Enzyminhibitoren
PT1173436E (pt) Derivado de tiazolidinodiona e sua utilizacao como antidiabetico
PT1173437E (pt) Derivado de tiazolidinodiona e sua utilizacao como antidiabetico
PT1066284E (pt) Derivados de benzo [c] quinolizina e sua utilizacao como inibidores de 5-alfa-redutases
PT1121349E (pt) Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta
DE69931607D1 (de) Lipasevariante
PT1077945E (pt) Isoquinolinas como inibidores de uroquinase
PT1200409E (pt) Derivados de isoquinolina substituida e a sua utilizacao como anticonvulsivos
DE29718933U1 (de) Hufeisen
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos